Jupiter Formulations Private Limited
About Jupiter Formulations Private Limited
Data last updated:
Jupiter Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 09 June 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21002MH2023PTC404582. Its GSTIN is 18AAGCJ0421K1ZO (Assam).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹24 Lakh. It is led by directors including Sachi Keshan and Rajesh Sood.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹10.29 Lakh (net margin 8.3%) and EBITDA of ₹12.81 Lakh (EBITDA margin 10.3%).
As per MCA filings, the company has open charges of ₹30 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – 309 Crystal Plaza, Premises Co – Operative Soc, Mumbai, Maharashtra, India – 400053
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Jupiter Formulations Private Limited
The main business activity of Jupiter Formulations is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Jupiter Formulations Private Limited FY 2025 filings available
Jupiter Formulations Private Limited reported revenue of ₹1.25 Cr (up 2045% YoY) for FY 2025.
Financial Statement Summary of Jupiter Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹12.81 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹10.29 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Jupiter Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 10.3% | •••• |
| Net Profit Margin | 8.3% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jupiter Formulations are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Jupiter Formulations Private Limited
Jupiter Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Latika Biotech Private Limited | ₹1.25 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Kolkata, West Bengal, India |
| Green Vein Health Care Private Limited | ₹1.25 Cr (FY 2025) | •••• | •••• | •••• | Thrissur, Kerala, India | |
| Aten Remedies Private Limited | ₹1.25 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Thane, Maharashtra, India |
| Opes Creations Private Limited | ₹1.25 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Panvel, Maharashtra, India |
| Deify Pharma Private Limited | ₹1.25 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Secunderabad, Telangana, India |
| Jupiter Formulations Private Limited this company | ₹1.25 Cr (FY 2025) | •••• | •••• | 2045.0% | •••• | Mumbai, Maharashtra, India |
| Medlink Pharma Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Ahmedabad, Gujarat, India |
| Riqfame Critical Care Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | 107.0% | •••• | Panchkula, Haryana, India |
| Zivon Lifecare Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Ahmedabad, Gujarat, India |
| Altar Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Zirakpur, Punjab, India |
| Quantumlife Sciences Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | 199.0% | •••• | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Jupiter Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Jupiter Formulations Private Limited
Jupiter Formulations has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachi Keshan Also directs: Kuno Pharma Private Limited, Prarthik Finserv Private Limited | Director | 09 Jun 2023 | 3 Years 4 Months | Current |
| Rajesh Sood | Director | 22 Nov 2024 | 1 Years 10 Months | Current |
| Pramod Keshan | Director | 09 Jun 2023 | 3 Years 4 Months | Current |
Charges & Borrowings of Jupiter Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Nov 2025 | Others | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Jupiter Formulations Private Limited
Employment history and EPFO contributions of people linked to Jupiter Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Jupiter Formulations Private Limited
Jupiter Formulations Private Limited has 5 board changes on record since 2023: 3 appointments and 2 cessations. The latest: Rajesh Sood was appointed as Director on 22 Nov 2024.
Credit Ratings, Litigation & Regulatory Alerts for Jupiter Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jupiter Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jupiter Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Jupiter Formulations Private Limited
Jupiter Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAGCJ0421K1ZO | Assam | Active | 30 Jun 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jupiter Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jupiter Formulations Private Limited
Jupiter Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 09 June 2023 (3+ years old) and is registered under CIN U21002MH2023PTC404582.
Jupiter Formulations reported revenue of ₹1.25 Cr for FY 2025 (up 2045% YoY).
Jupiter Formulations has 3 current directors:
- Sachi Keshan - Director
- Rajesh Sood - Director
- Pramod Keshan - Director
Jupiter Formulations reported a net profit of ₹10.29 Lakh (net margin 8.3%) and EBITDA of ₹12.81 Lakh (EBITDA margin 10.3%) for FY 2025, as per its filed financial statements.
The GSTIN of Jupiter Formulations is 18AAGCJ0421K1ZO, registered in Assam.
The CIN (Corporate Identification Number) of Jupiter Formulations is U21002MH2023PTC404582. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jupiter Formulations was incorporated on 09 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Jupiter Formulations by revenue are Latika Biotech Private Limited, Green Vein Health Care Private Limited, Aten Remedies Private Limited, Opes Creations Private Limited, Deify Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Rajesh Sood was appointed as Director on 22 Nov 2024. Manas Protim Gogoi ceased to be Director on 24 Jun 2024. Saroj Keshan ceased to be Director on 24 Jun 2024. Jupiter Formulations has 5 board changes on record in total.
The registered office of Jupiter Formulations is at E – 309 Crystal Plaza, Premises Co – Operative Soc, Mumbai, Maharashtra, India – 400053.
Jupiter Formulations has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹24 Lakh.